Company profile: Symphony Health
1.1 - Company Overview
Company description
- Provider of pharmaceutical and healthcare data powered by innovation and technology to address the fast-moving, highly complex healthcare environment. Supports decisions from market-sizing through sales compensation and payer reimbursement to help maximize brand performance and optimize sales team time.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Symphony Health
Promium
HQ: United States
Website
- Description: Provider of environmental information management software for commercial and public sector organizations, offering LIMS solutions that enhance productivity and regulatory compliance through intuitive workflows, dynamic analytics, and robust data management; comprehensive environmental laboratory testing workflows; water analysis workflow support; and a cloud-based platform integrating data and workflows for efficient, compliant lab operations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Promium company profile →
Applied BioMath
HQ: United States
Website
- Description: Provider of advanced mathematical and systems biology-driven support to help biotechnology and pharmaceutical companies accelerate and de-risk drug research and development, reducing late-stage attrition by applying these techniques at critical decision points in the drug discovery process.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Applied BioMath company profile →
Cellarity
HQ: United States
Website
- Description: Provider of AI and single-cell omics–driven drug discovery solutions, including the Cellarity Platform to address cellular dysfunction across diseases; the Intervention Library to predict perturbation impacts on cell behaviors; the Cellarity Map to identify gene networks from health to disease; a drug discovery pipeline in hematology and immunology; and a MASH collaboration with Novo Nordisk.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cellarity company profile →
Allcyte
HQ: Austria
Website
- Description: Provider of functional drug testing in primary human material using the Pharmacoscopy high-content imaging platform and AI-supported image analysis pipelines to advance precision and personalized medicine for cancer patients and treating physicians, while supporting pharmaceutical companies in drug development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Allcyte company profile →
RxS
HQ: United States
Website
- Description: Provider of end-to-end multi-channel sample management solutions, including LinkedRx for compliant management of pharmaceutical samples across hand-carry and direct-to-practitioner channels; TeleTargetRx contact center CRM for inside sales and sample requests; SampleCentral eSampling portal for healthcare professionals; RxS Engage telesampling and support services; and ClientConnect multi-channel reporting and analytics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full RxS company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Symphony Health
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Symphony Health
2.2 - Growth funds investing in similar companies to Symphony Health
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Symphony Health
4.2 - Public trading comparable groups for Symphony Health
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →